Impact of MenAfriVac in nine countries of the African meningitis belt, 2010–15: an analysis of surveillance data CL Trotter, C Lingani, K Fernandez, LV Cooper, A Bita, C Tevi-Benissan, ... The Lancet infectious diseases 17 (8), 867-872, 2017 | 220 | 2017 |
The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study K Hampson, F Ventura, R Steenson, R Mancy, C Trotter, L Cooper, ... The Lancet Infectious Diseases 19 (1), 102-111, 2019 | 85 | 2019 |
Pareto rules for malaria super-spreaders and super-spreading L Cooper, SY Kang, D Bisanzio, K Maxwell, I Rodriguez-Barraquer, ... Nature communications 10 (1), 3939, 2019 | 66 | 2019 |
Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with … LV Cooper, AS Bandyopadhyay, N Gumede, O Mach, P Mkanda, ... The Lancet Infectious Diseases 22 (2), 284-294, 2022 | 35 | 2022 |
Heterogeneous exposure and hotspots for malaria vectors at three study sites in Uganda SY Kang, KE Battle, HS Gibson, LV Cooper, K Maxwell, M Kamya, ... Gates Open Research 2, 2018 | 34* | 2018 |
Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis LV Cooper, PA Kristiansen, H Christensen, CL Trotter European Meningococcal and Haemophilus Disease Society, 2017 | 33 | 2017 |
Short-term forecasts of COVID-19 deaths in multiple countries S Bhatia, A Cori, KV Parag, S Mishra, LV Cooper, KEC Ainslie, ... Online Rep, 04-15, 2020 | 30 | 2020 |
Risk factors for acquisition of meningococcal carriage in the African meningitis belt LV Cooper, A Robson, CL Trotter, A Aseffa, JM Collard, DM Daugla, ... Tropical Medicine & International Health 24 (4), 392-400, 2019 | 20 | 2019 |
Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: Analysis of outbreak data from Ghana LV Cooper, JM Stuart, C Okot, F Asiedu-Bekoe, OK Afreh, K Fernandez, ... Vaccine 37 (37), 5657-5663, 2019 | 12 | 2019 |
Spatiotemporal analysis of serogroup C meningococcal meningitis spread in Niger and Nigeria and implications for epidemic response LV Cooper, O Ronveaux, K Fernandez, C Lingani, K Goumbi, ... The Journal of Infectious Diseases 220 (Supplement_4), S244-S252, 2019 | 10 | 2019 |
Pneumococcal Meningitis Outbreaks in Africa, 2000–2018: systematic literature review and meningitis surveillance database analyses K Franklin, B Kwambana-Adams, FC Lessa, HM Soeters, L Cooper, ... The Journal of Infectious Diseases 224 (Supplement_3), S174-S183, 2021 | 9 | 2021 |
Investigation of correlates of protection against pharyngeal carriage of Neisseria meningitidis genogroups W and Y in the African meningitis belt LV Cooper, RM Boukary, A Aseffa, W Mihret, JM Collard, D Daugla, ... PLoS One 12 (8), e0182575, 2017 | 8 | 2017 |
Effectiveness of poliovirus vaccines against circulating vaccine-derived type 2 poliomyelitis in Nigeria between 2017 and 2022: a case-control study LV Cooper, TB Erbeto, AA Danzomo, HW Abdullahi, K Boateng, ... The Lancet Infectious Diseases, 2024 | 7 | 2024 |
Time taken to detect and respond to polio outbreaks in Africa and the potential impact of direct molecular detection and nanopore sequencing AG Shaw, LV Cooper, N Gumede, AS Bandyopadhyay, NC Grassly, ... The Journal of infectious diseases 226 (3), 453-462, 2022 | 7 | 2022 |
Continuing risk of meningitis due to Neisseria meningitidis serogroup C in Africa: revised recommendations from a WHO expert consultation–Risque persistant de méningite due à … O mondiale de la Santé, World Health Organization Weekly Epidemiological Record= Relevé épidémiologique hebdomadaire 92 (41 …, 2017 | 5 | 2017 |
First Africa-based clinical trial for novel type 2 oral poliovirus vaccine LV Cooper, IM Blake The Lancet, 2024 | | 2024 |
Reducing the Burden of Bacterial Meningitis in the African Meningitis Belt After MenAfriVac L Cooper | | 2021 |